Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.
about
Clinical outcome measures in juvenile idiopathic arthritisFinding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre studyPhysician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records.2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept CohortProtocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA.A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptIs it time to move to active comparator trials in juvenile idiopathic arthritis?: a review of current study designs.Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.Emerging drugs to treat juvenile idiopathic arthritis.Optimization of pediatric rheumatology therapeutics.Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis.Disease activity measures in paediatric rheumatic diseasesHow common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score.Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.Developing a provisional definition of flare in patients with established gout.It is worth including assessment of disease activity state in juvenile arthritis clinical trials.Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis.
P2860
Q26752701-E05FC14C-6598-4808-8B53-486BB5F33B15Q26786198-C530AA5C-BA82-4954-96D5-BB1C721D3704Q33872872-669D96EC-CC34-4A07-B9EB-065FCFE3A873Q35567870-75813756-A11D-4161-B1DC-CA0D0AE565F7Q36795982-06D5E446-6E3D-4362-B884-19E2606DD97FQ37272672-B21A3CCF-E089-4508-8F9F-68B889139872Q37479820-1E97F596-3B21-4909-8425-95BFAE10F14FQ37518319-0A2A7334-3803-4B0F-AB6C-076FFCDA98E6Q37775937-C6CE8830-703B-450E-8781-A529B098A7DCQ37866288-DC79BEAA-42CE-4A02-83DB-5DD346E68A14Q37870209-ADC7AD34-169E-4535-BB35-314F276C7940Q37991520-ECD30C98-8102-471D-A94D-C9FED3BAC2CDQ38102977-0EC6CA5E-4023-439F-9B35-EEAFFD44F270Q38148751-3BFE0DA0-1A61-45A1-BFD8-EA8052706C71Q38847169-AF67FE0B-C3B6-42CD-8359-2D6AFEC45189Q43484603-A0DF996A-119F-44DA-9107-ABB9BDA16CB0Q44541879-E470F6B6-0999-41C5-95C5-0D96C6D7652AQ45685779-795F0F09-40FE-4BF1-8432-9DF3754D516CQ46709771-5B1B4916-E51A-4F20-805A-539510F8E989Q47150341-3F0578C9-8810-40C8-85EA-3A29F2A4B74DQ53150640-FABF48D6-F73D-4330-9347-2F48C1D6E479
P2860
Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Development and validation of ...... juvenile idiopathic arthritis.
@en
type
label
Development and validation of ...... juvenile idiopathic arthritis.
@en
prefLabel
Development and validation of ...... juvenile idiopathic arthritis.
@en
P2093
P50
P356
P1476
Development and validation of ...... juvenile idiopathic arthritis
@en
P2093
Alberto Martini
Chiara Cugno
Elena Bozzola
Elena Palmisani
Elena Sala
Nicoletta Solari
Nicolino Ruperto
P304
P356
10.1002/ART.23916
P577
2008-08-01T00:00:00Z